Neutropenia, agranulocytosis and dipyrone
Keywords:
Agranulocytosis, Neutropenia, Dipyrone, Incidence, Case-control studiesAbstract
CONTEXT: Neutropenia and agranulocytosis may be defined as granulocyte counts of less than 1,500/mm3 and 500/mm3, respectively. Agranulocytosis is a rare and serious disease often caused by drugs. Its mortality rate is around 10%. The most common manifestations are infections such as tonsillitis, pharyngitis, stomatitis or pneumonia. Although dipyrone is one of the drugs known to be associated with agranulocytosis, the strength of the association has been a matter of much debate. Moreover, alternative analgesic and antipyretic agents are not devoid of serious side effects. CONCLUSIONS: It is therefore necessary to establish the incidence of agranulocytosis in Latin America and the role of dipyrone. The on- going LATIN Study is a multicenter international case-control study that will provide answers for these questions.
Downloads
References
Watts RG. Neutropenia. In: Greer JP, Foerster J, Lukens JN, Rodgers GM., Paraskevas F, Glader BE. Wintrobe’s Clinical Hematology. 11th edition. Philadelphia: Lippincott Williams & Wilkins; 2004. 1777-95.
Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press; 1991.
Kaufman DW, Kelly JP, Jurgelon JM, et al. Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl. 1996;60:23-30.
Maluf EM, Pasquini R, Eluf JN, Kelly J, Kaufman DW. Aplastic anemia in Brazil: incidence and risk factors. Am J Hematol. 2002;71(4):268-74.
Hamerschlak N, Montezuma MP, Bacal N, Szterling LN, Rosen- feld LG, Guerra CC. Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of São Paulo-Brazil. Rev Paul Med. 1993;111(1):294-8.
Hamerschlak N, Maluf E, Pasquini R, et al. Incidence of aplastic anemia and agranulocytosis in Latin America: the LATIN study. Sao Paulo Med J. 2005;123(3):101-4.
Agência Nacional de Vigilância Sanitária. Resolution RE no 1260, de 15 de agosto de 2001. Determina a publicação do Relatório Final do “Painel Internacional de Avaliação da Segurança da Dipirona”.D.O.U. – Diário Oficial da União; Pode Executivo, de 16 de agosto de 2001. Available at URL: http://e-legis.bvs.br/leisref/public/show-Act.php?id=2407&word. Accessed in 2005 (July 26).
